Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Global NGS-based RNA-seq Market to Reach $4.4 Billion by 2026


SAN FRANCISCO, Oct. 21, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "NGS-based RNA-seq - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 9; Released: April 2021
Executive Pool: 3213
Companies: 46 - Players covered include Agilent Technologies, Inc.; Eurofins Scientific; F. Hoffmann-La Roche AG; GATC Biotech AG; Illumina, Inc.; Macrogen, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; Qiagen NV; Thermo Fisher Scientific, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Application (De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics, Small RNA Sequencing); End-Use (Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses); Products & Services (Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services, Data Analysis, Storage, and Management); Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing, Nanopore Sequencing)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlasstm Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global NGS-based RNA-seq Market to Reach $4.4 Billion by 2026
Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 19.9% over the analysis period. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $535.8 Million in 2021, While China is Forecast to Reach $777.3 Million by 2026
The NGS-based RNA-seq market in the U.S. is estimated at US$535.8 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$777.3 Million by the year 2026 trailing a CAGR of 19.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.

RNA Sequencing Services Segment to Reach US$1.1 Billion by the year 2026
In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. More

MarketGlasstm Platform
Our MarketGlasstm Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyRtm
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: ZA@StrategyR.com

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
Info411@strategyr.com

SOURCE Global Industry Analysts, Inc.


These press releases may also interest you

at 03:00
Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof. Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) on November 26, the 2020...

at 00:00
Trails Carolina, the leader in wilderness therapy for pre-teens and teens, teamed up with the Arkansas Institute of Developmental Science and the Center for Research, Assessment, and Treatment Efficacy to assess the impacts on youth and their...

26 nov 2021
Public Health Agency of Canada The Government of Canada is working with partners to protect the health and safety of Canadians and Temporary Foreign Workers in Canada, and to reduce the spread of COVID-19 and its variants in Canada. Self-isolation is...

26 nov 2021
Public health authorities in South Africa have confirmed that a new COVID-19 variant of concern (B.1.1.529) has been detected in that country. Over the past 24 hours, this variant ? named Omicron by the World Health Organization ? has also been...

26 nov 2021
CARESPAN HEALTH, INC. (formerly Dynamo Capital Corp.) ("CareSpan" or the "Company") is pleased to announce that, subject to the approval of the TSX Venture Exchange (the "TSX-V"), it has engaged the services of Generation IACP Inc. ("Generation") to...

26 nov 2021
Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing "Psychedelics to Therapeuticstm", is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved...



News published on 21 october 2021 at 10:30 and distributed by: